Efficacy of Romosozumab and Denosumab Combined Treatment in Postmenopausal Osteoporosis Patients with Multiple Fragility Fractures

NCT06720350 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Osteoporosis in Post-menopausal Women

Interventions

DRUG: Romosozumab and Denosumab Combination Therapy
DRUG: Romosozumab Prefilled Syringe [Evenity]
DRUG: Denosumab (Prolia)

Sponsor

Marmara University